|

Nivolumab 10 MG/ML Intravenous Solution Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • University Hospital, Essen1
  • Jules Bordet Institute1

Indications

  • Cancer2
  • NSCLC, Stage IIIA1
  • NSCLC Stage II1
  • Rectal Cancer Stage III1
  • Rectal Cancer Stage II1

Other2 trials

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
Phase 2
Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.